Insider: Mathew Aby J. EVP & Chief Scientific Officer - BIOLIFE SOLUTIONS INC
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 351,421 | 0 | 351,421 |
| Value | $8,680,098.70 | $0.00 | $8,680,098.70 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 09/11/2025 | DDS | 630 | Direct | COM | $26.83 | $16,902.90 | 351,421 |
| 08/26/2025 | DDS | 531 | Direct | COM | $25.44 | $13,508.64 | 352,051 |
| 07/07/2025 | DDS | 536 | Direct | COM | $22.27 | $11,936.72 | 352,582 |
| 06/10/2025 | DDS | 637 | Direct | COM | $23.70 | $15,096.90 | 353,118 |
| 05/28/2025 | DDS | 521 | Direct | COM | $22.46 | $11,701.66 | 308,486 |
| 04/09/2025 | DDS | 569 | Direct | COM | $20.11 | $11,442.59 | 309,007 |
| 04/01/2025 | DDS | 10,589 | Direct | COM | $22.66 | $239,946.74 | 309,576 |
| 03/11/2025 | DDS | 1,597 | Direct | COM | $25.00 | $39,925.00 | 260,601 |
| 03/03/2025 | DDS | 425 | Direct | COM | $25.46 | $10,820.50 | 262,198 |
| 02/12/2025 | DDS | 92 | Direct | COM | $26.54 | $2,441.68 | 262,623 |
| 01/06/2025 | DDS | 404 | Direct | COM | $27.02 | $10,916.08 | 262,715 |
| 12/17/2024 | DDS | 13,196 | Direct | COM | $27.16 | $358,403.36 | 263,119 |
| 12/16/2024 | DDS | 7,604 | Direct | COM | $27.33 | $207,817.32 | 276,315 |
| 11/26/2024 | DDS | 523 | Direct | COM | $27.20 | $14,225.60 | 283,919 |
| 11/18/2024 | DDS | 17,604 | Direct | COM | $20.05 | $352,960.20 | 284,442 |
| 11/15/2024 | DDS | 10,000 | Direct | COM | $21.16 | $211,600.00 | 317,046 |
| 11/15/2024 | DDS | 15,000 | Direct | COM | $21.17 | $317,550.00 | 302,046 |
| 11/12/2024 | DDS | 123 | Direct | COM | $26.34 | $3,239.82 | 317,046 |
| 10/30/2024 | DDS | 547 | Direct | COM | $23.15 | $12,663.05 | 317,169 |
| 10/16/2024 | DDS | 10,000 | Direct | COM | $23.17 | $231,700.00 | 317,716 |
| 10/15/2024 | DDS | 10,000 | Direct | COM | $23.28 | $232,800.00 | 317,716 |
| 09/19/2024 | DDS | 10,000 | Direct | COM | $25.47 | $254,700.00 | 317,716 |
| 09/18/2024 | DDS | 10,000 | Direct | COM | $23.90 | $239,000.00 | 317,716 |
| 09/16/2024 | DDS | 343 | Direct | COM | $25.12 | $8,616.16 | 317,716 |
| 08/21/2024 | DDS | 111 | Direct | COM | $25.61 | $2,842.71 | 318,059 |
| 1 2 3 4 5 6 Next Last You are at page 1 of 6 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research